The asserted claims of a DuPont patent disclosing a process for preparing flexographic printing plates were invalid as obvious over prior art and therefore could not support infringement contentions…
Therapeutic effect of a 2-10mg once yearly dosage regimen is made plausible by an example showing clinical effect of dosage regimens of 0.25, 0.50 and 1mg per three months, 2.0 mg every six months…
The High Court has granted the Claimants’ request for declarations of non-infringement ("DNIs") regarding several national designations of the Defendant’s European Patent for a pemetrexed disodium…
One of the possible methods to examine incentive activity is what is known as the "problem and solution approach" usually applied by the European Patent Office ("EPO"). Spanish Courts like this…
by Claire Phipps-Jones
The Patents Court has recently determined two questions relating to groundless threats: first, can a threat made on the basis of a patent application be justified once the…
The Patent Trial and Appeal Board did not err in affirming a patent examiner’s rejection of three claims of an IPCom patent on a system for allowing access rights to cell phone channels, the U.S…
An EPO board held that observations filed by third parties during inter partes appeal must be disregarded by the board, unless they concern amendments during opposition or appeal, in which case the…
The Danish Maritime and Commercial Court recently rendered judgement (SH2016.T-5-14)
in a matter between Ametek Denmark A/S and the intellectual property consultancy Zacco Denmark A/S. As an external…
A federal trial court erroneously concluded that patent defendant Suunto Oy lacked minimum contacts with the State of Delaware to support the assertion of specific personal jurisdiction in a patent…
